Find D-Panthenol manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

USP

0

JP

FDF DossiersDRUG PRODUCT COMPOSITIONS

288RELATED EXCIPIENT COMPANIES

497EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: D-panthenol, 81-13-0, Pantothenol, Ilopan, D-pantothenyl alcohol, Bepanthen
Molecular Formula
C9H19NO4
Molecular Weight
205.25  g/mol
InChI Key
SNPLKNRPJHDVJA-ZETCQYMHSA-N
FDA UNII
1O6C93RI7Z

D-Panthenol
Dexpanthenol is a metabolite found in the aging mouse brain.
1 2D Structure

D-Panthenol

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R)-2,4-dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutanamide
2.1.2 InChI
InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1
2.1.3 InChI Key
SNPLKNRPJHDVJA-ZETCQYMHSA-N
2.1.4 Canonical SMILES
CC(C)(CO)C(C(=O)NCCCO)O
2.1.5 Isomeric SMILES
CC(C)(CO)[C@H](C(=O)NCCCO)O
2.2 Other Identifiers
2.2.1 UNII
1O6C93RI7Z
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (+)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutyramide

2. 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutanamide

3. Bepanthen

4. Butanamide, 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethyl-, (+--)-

5. Corneregel

6. D-panthenol

7. Dexpanthenol Heumann

8. Dl-panthenol

9. Ilopan

10. Marolderm

11. Nasenspray Ratiopharm Panthenol

12. Nasicur

13. Otriven Dexpanthenol

14. Pan Rhinol

15. Pan-ophtal

16. Panthenol

17. Panthenol Braun

18. Panthenol Jenapharm

19. Panthenol Law

20. Panthenol Lichtenstein

21. Panthenol Von Ct

22. Panthenol-ratiopharm

23. Panthoderm

24. Panthogenat

25. Pantothenol

26. Repa-ophtal

27. Rhinoclir

28. Siozwo Sana

29. Ucee D

30. Urupan

31. Wund- Und Heilsalbe Law

2.3.2 Depositor-Supplied Synonyms

1. D-panthenol

2. 81-13-0

3. Pantothenol

4. Ilopan

5. D-pantothenyl Alcohol

6. Bepanthen

7. Pantol

8. Bepanthene

9. Bepantol

10. (+)-panthenol

11. Provitamin B

12. Motilyn

13. Panadon

14. Panthoderm

15. Thenalton

16. Zentinic

17. D-pantothenol

18. Pantothenyl Alcohol

19. Cozyme

20. D-p-a Injection

21. D(+)-panthenol

22. Pantenyl

23. Synapan

24. Urupan

25. D(+)-pantothenyl Alcohol

26. Intrapan

27. D Panthenol

28. D-panthenol 50

29. Provitamin B5

30. Pantothenylol

31. (2r)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutanamide

32. Dexpantenol

33. (r)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutanamide

34. Dextro Pantothenyl Alcohol

35. Propanolamine, N-pantoyl-

36. Dexpanthenolum

37. Alcopan-250

38. Penthenol

39. Varitan

40. N-pantoyl-propanolamine

41. Panthenol (d)

42. Butanamide, 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethyl-, (2r)-

43. Panthenol (jan)

44. Prestwick_529

45. Dexpanthenol (1.20 G/ml)

46. Ilopan (tn)

47. D-(+)-panthenol

48. Panthenol, (+)-

49. D-(+)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutyramide

50. N-pantoyl-3-propanolamine

51. Nsc 302962

52. D-(+)-pantothenyl Alcohol

53. 1o6c93ri7z

54. Chebi:27373

55. Butanamide, 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethyl-, (r)-

56. Pro-itamin B5

57. Butyramide, 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethyl-, D-(+)-

58. Component Of Pantho-f

59. Ncgc00142622-03

60. Panthenol [jan]

61. 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutanamide, (r)-

62. 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutyramide, D-(+)-

63. Dsstox_cid_2906

64. Dsstox_rid_76783

65. Dsstox_gsid_22906

66. Panthenolum

67. Pantenol

68. Pantenolo

69. Sinecort

70. (r)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutyramide

71. D(+)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutyramide

72. Component Of Zentinic

73. Pantothenol, D-

74. Alcool Dl-pantotenilico

75. (+-)-pantothenyl Alcohol

76. Dexpanthenol [usan]

77. Dexpantenol [inn-spanish]

78. Dexpanthenolum [inn-latin]

79. Unii-1o6c93ri7z

80. (r)-2,4-dihydroxy-3,3-dimethylbutyric 3-hydroxypropylamide

81. Dexpanthenol;

82. Ccris 3947

83. Hsdb 296

84. Nsc302962

85. Fancol Dl

86. Nsc-302962

87. Cas-81-13-0

88. Ncgc00186658-01

89. Dexpanthenol [usan:usp:inn:ban]

90. Einecs 201-327-3

91. Dexpanthenol (usp)

92. Mfcd00065006

93. Cornergel

94. Dolobene

95. Bay 81-2996

96. Brn 1724947

97. Panthenol, (+ )-

98. Panthenol 50w

99. Prestwick0_000022

100. Prestwick1_000022

101. Prestwick2_000022

102. Prestwick3_000022

103. Dexpanthenol (usp/inn)

104. Dexpanthenol [mi]

105. D-panthenol Usp/bp/ip

106. Compnent Of Ilopan-choline

107. Dexpanthenol [fcc]

108. Dexpanthenol [inn]

109. Bmse000445

110. Panthenol, (r)-

111. Dexpanthenol [hsdb]

112. Ec 201-327-3

113. Alcopan 250

114. D-panthenol [vandf]

115. Dexpanthenol [vandf]

116. Schembl15861

117. Bspbio_000083

118. Dexpanthenol [mart.]

119. 4-04-00-01652 (beilstein Handbook Reference)

120. Dexpanthenol [usp-rs]

121. Dexpanthenol [who-dd]

122. Spbio_002004

123. Bpbio1_000093

124. Chembl1200979

125. Dexpanthenol - Usp/fcc Kosher

126. Dtxsid3022906

127. Schembl20553090

128. Dexpanthenol [orange Book]

129. Hms1568e05

130. Hms2094e09

131. Hms2095e05

132. Hms3712e05

133. Dexpanthenol [ep Monograph]

134. (r)-2,4-dihydroxy-n-(3-hydroxy-propyl)-3,3-dimethylbutanamide

135. Hy-b1391

136. Zinc1530303

137. D-panthenol, >=98.0% (nt)

138. Dexpanthenol [usp Monograph]

139. Tox21_111563

140. Lmfa08020198

141. S4695

142. Akos015841507

143. Akos015901947

144. Calcium D-pantothenate Usp/bp/ep/ip

145. D(+)-alpha,gamma-dihydroxy-n-(3-hydroxypropyl)-beta,beta-dimethylbutyramide

146. Tox21_111563_1

147. Ccg-213429

148. Cs-8175

149. Db09357

150. Alpha,gamma-dihydroxy-n-(3-hydroxypropyl)-beta,beta-dimethylbutyramide, D-(+)-

151. Ncgc00142622-01

152. Ncgc00142622-04

153. As-14732

154. D-panthenol 10 Microg/ml In Acetonitrile

155. Dexpanthenol, Tested According To Ph.eur.

156. Sbi-0206936.p001

157. D-panthenol, Vetec(tm) Reagent Grade, 98%

158. P0692

159. C05944

160. D00193

161. D70909

162. Q-201048

163. Q47495755

164. A6cf1a81-5b98-4c28-a379-ea28fa9dd210

165. (r)-3-(2,4-dihydroxy-3,3-dimethylbutyramido)-1-propanol

166. Dexpanthenol, European Pharmacopoeia (ep) Reference Standard

167. (2r)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethyl-butanamide

168. (r)-()-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutyramide

169. (r)-(+)-2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutanamide

170. (r)-2,4-dihydroxy-3,3-dimethyl-n-(3-hydroxypropyl)-butanamide

171. (r)-2,4-dihydroxy-n-(3-hydroxy-propyl)-3,3-dimethyl-butyramide

172. D-(+)-2,4-dihydroxy-3,3-dimethyl-n-(3-hydroxypropyl)butyramide

173. D-panthenol, >=98% (perchloric Acid Titration), >=98% (tlc)

174. Dexpanthenol, United States Pharmacopeia (usp) Reference Standard

175. (d)-(+)-2, 4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethylbutyramide

176. Butanamide, 2,4-dihydroxy-n-(3-hydroxypropyl)-3,3-dimethyl-, (theta)-

177. D(+)-.alpha.,.gamma.-dihydroxy-n-(3-hydroxypropyl)-.beta.,.beta.-dimethylbutyramide

178. Dexpanthenol, Pharmaceutical Secondary Standard; Certified Reference Material

179. 1113-70-8

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 205.25 g/mol
Molecular Formula C9H19NO4
XLogP3-0.9
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count4
Rotatable Bond Count6
Exact Mass205.13140809 g/mol
Monoisotopic Mass205.13140809 g/mol
Topological Polar Surface Area89.8 Ų
Heavy Atom Count14
Formal Charge0
Complexity182
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

Dexpanthenol (topical) relieves itching and aids healing of skin in mild eczemas and dermatoses; itching skin, minor wounds, stings, bites, poison ivy, poison oak (dry sage) and minor skin irritations. Also, used in infants and children for diaper rash, chafing and mild skin irritations.

Novak, K.M. (ed.). Drug Facts and Comparisons2008 Edition. Wolters Kluwer Health. St. Louis, Missouri 2008., p. 2636


Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or post partum retention of flatus, or post operative delay in resumption of intestinal motility; paralytic ileus.

Novak, K.M. (ed.). Drug Facts and Comparisons2008 Edition. Wolters Kluwer Health. St. Louis, Missouri 2008., p. 1767


Vet: ... Dexpanthenol ... /is/ often used as source of B5. Only the D-isomers are active biologically, but dl-isomers are often used ... Equivalents: 1 g D-pantothenic acid = 936 mg D-dexpanthenol.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 645


/Exptl Use (Vet)/: The effect of B-complex vitamin on experimental liver damage in rats was studied. Ip injection of panthenol inhibited initial deposit of lipids after having removed 2/3 of the regenerating fatty liver in rats.

PMID:4235781 Petzold H, Weigel K; Int Z Vitaminforsch 38 (1): 97 (1968)


For more Therapeutic Uses (Complete) data for Dexpanthenol (13 total), please visit the HSDB record page.


4.2 Drug Warning

Administration of dexpanthenol injection directly into the vein is not advised.

Novak, K.M. (ed.). Drug Facts and Comparisons2008 Edition. Wolters Kluwer Health. St. Louis, Missouri 2008., p. 1767


One case of heartburn and a few cases of GI cramps have been reported after dexpanthenol administration. Allergic reactions to dexpanthenol have been reported occasionally; however, these reactions have not been directly attributed to the drug. Although isolated reports of itching, tingling, difficulty in breathing, erythema, generalized dermatitis, urticaria, temporary respiratory difficulty (when dexpanthenol injection was administered 5 minutes after succinylcholine had been discontinued), hypotension, persistent (up to 10 days) diarrhea, and agitation have been associated with use of dexpanthenol injection, a causal relationship to the drug has not been established.

American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)


It is not known whether dexpanthenol can cause fetal harm when administered to pregnant women. Dexpanthenol injection should be used during pregnancy only when clearly needed.

American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)


Dexpanthenol injection should not be used for the management of mechanical obstruction; in these patients, therapy should be directed mainly at correcting the obstruction. The manufacturer of dexpanthenol injection cautions that the management of adynamic ileus includes correction of fluid and electrolyte abnormalities (especially hypokalemia), anemia, and hypoproteinemia; treatment of infection; avoidance of drugs that decrease GI motility; and decompression of the GI tract using nasogastric suction or a long intestinal tube when there is considerable distention.

American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)


For more Drug Warnings (Complete) data for Dexpanthenol (9 total), please visit the HSDB record page.


4.3 Drug Indication

Injection: Prophylactic use immediately after major abdominal surgery to minimize the possibility of paralytic ileus. Intestinal atony causing abdominal distention; postoperative or postpartum retention of flatus, or postoperative delay in resumption of intestinal motility; paralytic ileus. Topical: This medication is used as a moisturizer to treat or prevent dry, rough, scaly, itchy skin and minor skin irritations (e.g., diaper rash, skin burns from radiation therapy).


5 Pharmacology and Biochemistry
5.1 Pharmacology

Pantothenic acid is a precursor of coenzyme A, which serves as a cofactor for a variety of enzyme-catalyzed reactions involving transfer of acetyl groups. The final step in the synthesis of acetylcholine consists of the choline acetylase transfer of acetyl group from acetylcoenzyme A to choline. Acetylcholine is the neurohumoral transmitter in the parasympathetic system and as such maintains the normal functions of the intestine. Decrease in acetylcholine content would result in decreased peristalsis and in extreme cases adynamic ileus.


5.2 ATC Code

A - Alimentary tract and metabolism

A11 - Vitamins

A11H - Other plain vitamin preparations

A11HA - Other plain vitamin preparations

A11HA30 - Dexpanthenol


D - Dermatologicals

D03 - Preparations for treatment of wounds and ulcers

D03A - Cicatrizants

D03AX - Other cicatrizants

D03AX03 - Dexpanthenol


S - Sensory organs

S01 - Ophthalmologicals

S01X - Other ophthalmologicals

S01XA - Other ophthalmologicals

S01XA12 - Dexpanthenol


5.3 Absorption, Distribution and Excretion

Absorption

Dexpanthenol is soluble in water and alcohol, although insoluble in fats and oil based substances. With the appropriate vehicle, Dexpanthenol is easily penetrated into the skin. Rate of penetration and absorption is reduced when Dexpanthenol is administered as an oil/water formula.


Route of Elimination

Milk of nursing mothers receiving a normal diet contains about 2 ug of pantothenic acid per mL. About 70% of an oral dose of pantothenic acid is excreted unchanged in urine and about 30% in feces.


Volume of Distribution

Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A. Highest concentrations are found in the liver, adrenal glands, heart, and kidneys.


Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A. Highest concentrations are found in the liver, adrenal glands, heart, and kidneys. Milk of nursing mothers receiving a normal diet contains about 2 ug of pantothenic acid per mL. About 70% of an oral dose of pantothenic acid is excreted unchanged in urine and about 30% in feces.

American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)


5.4 Metabolism/Metabolites

Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.


Dexpanthenol is readily converted to pantothenic acid which is widely distributed into body tissues, mainly as coenzyme A.

American Society of Health System Pharmacists; AHFS Drug Information 2009. Bethesda, MD. (2009)


Dexpanthenol is converted to pantothenic acid ... which then produces acetylcholine.

Evaluations of Drug Interactions. 1st ed. and supplements. Washington, DC: American Pharmaceutical Assn., 1973, 1974., p. 396


5.5 Biological Half-Life

Half life have not been reported


5.6 Mechanism of Action

Dexpanthenol is an alcohol derivative of pantothenic acid, a component of the B complex vitamins and an essential component of a normally functioning epithelium. Dexpanthenol is enzymatically cleaved to form pantothenic acid, which is an essential component of Coenzyme A, which acts as a cofactor in many enzymatic reactions that are important for protein metabolism in the epithelium. Dermatological effects of the topical use of dexpanthenol include increased fibroblast proliferation and accelerated re-epithelialization in wound healing. Furthermore, it acts as a topical protectant, moisturizer, and has demonstrated anti-inflammatory properties.


This alcohol ... is said to increase the amount of coenzyme A available for the synthesis of acetylcholine. Increased formation of acetylcholine is thought to increase peristalsis and intestinal tone.

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 752


... To test the functional effect of pantothenate on dermal fibroblasts, cells were cultured and in vitro proliferation tests were performed using a standardized scratch test procedure. For all three donors analyzed, a strong stimulatory effect of pantothenate at a concentration of 20 ug/mL on the proliferation of cultivated dermal fibroblasts was observed. To study the molecular mechanisms resulting in the proliferative effect of pantothenate, gene expression was analyzed in dermal fibroblasts cultivated with 20 ug/mL of pantothenate compared with untreated cells using the GeneChip Human Exon 1.0 ST Array. A number of significantly regulated genes were identified including genes coding for interleukin (IL)-6, IL-8, Id1, HMOX-1, HspB7, CYP1B1 and MARCH-II. Regulation of these genes was subsequently verified by quantitative real-time polymerase chain reaction analysis. Induction of HMOX-1 expression by pantothenol and pantothenic acid in dermal cells was confirmed on the protein level using immunoblots. Functional studies revealed the enhanced suppression of free radical formation in skin fibroblasts cultured with panthenol. In conclusion, these studies provided new insight in the molecular mechanisms linked to the stimulatory effect of pantothenate and panthenol on the proliferation of dermal fibroblasts. /Calcium pantotenate/

Wiederholt T et al; Exper Dermatol 18 (11): 969-78 (2009). Available from, as of March 16, 2010: https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=19397697


... Pantothenic acid, pantothenol and other derivatives ... are precursors of CoA /that/ protect cells and whole organs against peroxidative damage by increasing the content of cell glutathione...

Slyshenkov V et al; FEBS Lett 569 (1-3): 169-72 (2004). Available from, as of March 16, 2010: https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15225628


USDMF

read-more
read-moreread-more

01

Dsm-firmenich Switzerland Ag

Netherlands

USDMF

arrow
Vietnam Medi-Pharm Expo
Not Confirmed

01

Vietnam Medi-Pharm Expo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2017-08-01

Pay. Date : 2017-01-09

DMF Number : 30723

Submission : 2016-09-02

Status : Active

Type : II

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more

01

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Certificate Number : R1-CEP 2006-233 - Rev 03

Status : Valid

Issue Date : 2021-04-22

Type : Chemical

Substance Number : 761

blank

02

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Certificate Number : R1-CEP 2006-108 - Rev 00

Status : Withdrawn by Holder

Issue Date : 2013-02-18

Type : Chemical

Substance Number : 761

blank

03

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Certificate Number : CEP 1997-113 - Rev 04

Status : Valid

Issue Date : 2025-07-11

Type : Chemical

Substance Number : 761

blank

04

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Certificate Number : R1-CEP 2008-319 - Rev 02

Status : Valid

Issue Date : 2021-07-13

Type : Chemical

Substance Number : 761

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

read-more
read-moreread-more

01

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Panthenol

Registration Number : 217MF11027

Registrant's Address : 10-50, Mukai-cho 2-chome, Furukawa-cho, Hida City, Gifu Prefecture

Initial Date of Registration : 2005-12-02

Latest Date of Registration : 2008-12-04

blank

02

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Panthenol D-Panthenol

Registration Number : 217MF11287

Registrant's Address : Wurmisweg 576 4303 Kaiseraugst

Initial Date of Registration : 2005-12-22

Latest Date of Registration : 2006-07-20

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

DEXPANTHENOL

NDC Package Code : 49452-2464

Start Marketing Date : 2024-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1.2kg/L)

Marketing Category : DRUG FOR FURTHER PROCESSING

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

BASF

Germany
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

BASF

Germany
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Dexpanthenol

About the Company : We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and alm...

We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and almost every country in the world. Our broad portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. In 2015, BASF posted sales of €70 billion and income from operations before special items of approximately €6.7 billion. We combine economic success with environmental protection and social responsibility. Through research and innovation, we support our customers in nearly every industry.
blank

02

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Panthenol

About the Company : Brother Enterprises Holding Co., Ltd. was founded in 1991 and is headquartered in Haining City, Zhejiang Province, China. With over 30 years of experience, Brother Enterprises has ...

Brother Enterprises Holding Co., Ltd. was founded in 1991 and is headquartered in Haining City, Zhejiang Province, China. With over 30 years of experience, Brother Enterprises has grown into an international chemical group, covering four business divisions – leather chemicals, vitamins, spices, and active pharmaceutical ingredients. There are also several wholly owned subsidiaries. Brother Enterprises has four manufacturing plants: three in China (Zhejiang Province, Jiangsu Province, and Jiangxi Province) and one in Newcastle, South Africa.
blank

03

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Dexpanthenol

About the Company : Welcome To The Most Famous And Reputed Manufacturer And Supplier For Pharmaceutical Products, Chemicals, Pharmaceutical Package Group In China. FENGCHEN GROUP CO., LTD Have Been Se...

Welcome To The Most Famous And Reputed Manufacturer And Supplier For Pharmaceutical Products, Chemicals, Pharmaceutical Package Group In China. FENGCHEN GROUP CO., LTD Have Been Serving The Clients All Over World For More Than 10 Years In Pharmaceutical & Chemical Industry, Especially South East Asia(Vietnam, Thailand, Singapore, Etc), CIS Countries (Russia, Uzbekistan, Belarus, Lithuania, Etc). With Our Scale Production And Overseas Market Sale Experiences, We Are Always The Top Choice For Our Clients. We Have Been Waiting For Your Esteemed Company To Work With Us. FENGCHEN GROUP Will Be Your Top Purchase Source From China. We Are Confid
blank

04

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Panthenol

About the Company : Jing Jing Pharmaceutical Co., Ltd., founded in October 2007, covers an area of 200 mu, registered capital of 257.28 million yuan, and employees of more than 700 people, is a high-t...

Jing Jing Pharmaceutical Co., Ltd., founded in October 2007, covers an area of 200 mu, registered capital of 257.28 million yuan, and employees of more than 700 people, is a high-tech enterprise specializing in the R&D, production, and marketing of sterile raw materials, amino acids, and vitamin nutrition fortifiers. The company's technical team has obtained more than 40 patents and 7 new product and new technology appraisals. The company has formed two series of products: one is sterile API products with crystallization technology; the other is an amino acid and vitamin series product with biological enzyme catalysis technology.
blank

05

Royal DSM

Netherlands
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

Royal DSM

Netherlands
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

D-Panthenol

About the Company : Royal DSM, founded in 1902, is a global, purpose-led health, nutrition, and bioscience company that specializes in human and animal health and nutrition solutions. Its primary goal...

Royal DSM, founded in 1902, is a global, purpose-led health, nutrition, and bioscience company that specializes in human and animal health and nutrition solutions. Its primary goal is to develop health and nutrition solutions that are scientifically sound. Royal DSM's products and solutions address some of the world's most pressing issues while also adding economic, environmental and societal value to all stakeholders. More than 2.5 billion people worldwide use the company's solutions. Royal DSM and its affiliated companies employ approximately 23,000 people worldwide and generate around €10 billion in net sales per year.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more

Details:

Ascorbic Acid, a vitamin/mineral/inorganic salt product, aims to prevent vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.


Lead Product(s): Ascorbic Acid,Vitamin A,Vitamin D3,Vitamin B1,Riboflavin,Pyridoxine Hydrochloride,Niacinamide,D-Panthenol,

Therapeutic Area: Nutrition and Weight Loss Brand Name: Infuvite Adult-Generic

Study Phase: Approved FDFProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: Apotex Inc

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 15, 2026

blank

01

Vietnam Medi-Pharm Expo
Not Confirmed
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Ascorbic Acid, a vitamin/mineral/inorganic salt product, aims to prevent vitamin deficiency in adults and children aged 11 and older receiving parenteral nutrition.

Product Name : Infuvite Adult-Generic

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

April 15, 2026

blank

Details:

Dexpanthenol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Wound Healing.


Lead Product(s): D-Panthenol,Inapplicable

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Brand Name: Undisclosed

Study Phase: Phase IVProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable April 12, 2016

blank

02

Bayer AG

Germany
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Bayer AG

Germany
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Dexpanthenol is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Wound Healing.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

April 12, 2016

blank
  • Development Update

Details:

Naphazoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Influenza, Human.


Lead Product(s): Naphazoline Hydrochloride,Pheniramine Maleate,D-Panthenol

Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Miscellaneous

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 15, 2012

blank

03

EMS

Brazil
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

EMS

Brazil
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Naphazoline is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Influenza, Human.

Product Name : Undisclosed

Product Type : Miscellaneous

Upfront Cash : Inapplicable

February 15, 2012

blank
  • Development Update

Details:

Royal Jelly is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Diabetic Foot.


Lead Product(s): Royal Jelly,D-Panthenol

Therapeutic Area: Podiatry Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Undisclosed

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable February 13, 2012

blank

04

European Egyptian Pharmaceutical Industries

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

European Egyptian Pharmaceutical Industries

Country
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

Details : Royal Jelly is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Diabetic Foot.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

February 13, 2012

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

Vietnam Medi-Pharm Expo
Not Confirmed
arrow
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E

Brand Name : M.V.C. 9+3

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;20 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ML;0.3MG/ML;330 UNITS/ML;1 IU/ML

Approval Date : 1985-08-08

Application Number : 18440

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

02

WATSON LABS

Ireland
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

WATSON LABS

Ireland
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E

Brand Name : MVC PLUS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;20 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ML;0.3MG/ML;330 UNITS/ML;1 IU/ML

Approval Date : 1985-08-08

Application Number : 18439

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

03

HOSPIRA

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

HOSPIRA

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E

Brand Name : M.V.I.-12 ADULT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 10MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;20 IU/ML;0.04MG/ML;4MG/ML;0.4MG/ML;0.36MG/ML;0.3MG/ML;330 UNITS/ML;1 IU/ML

Approval Date : 1985-08-08

Application Number : 8809

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

04

HOSPIRA

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

HOSPIRA

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E

Brand Name : M.V.I.-12 ADULT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 20MG/ML;0.006MG/ML;0.5MCG/ML;1.5MG/ML;20 IU/ML;0.6MG/ML;4MG/ML;0.4MG/ML;0.36MG/ML;0.6MG/ML;330 UNITS/ML;1 IU/ML

Approval Date : 2004-04-22

Application Number : 8809

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank

05

HOSPIRA

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

HOSPIRA

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E

Brand Name : M.V.I.-12 ADULT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

Approval Date : 2004-09-09

Application Number : 8809

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

06

HOSPIRA

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

HOSPIRA

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K

Brand Name : M.V.I. ADULT

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

Approval Date : 2004-01-30

Application Number : 21625

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

07

HOSPIRA

U.S.A
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

HOSPIRA

U.S.A
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K

Brand Name : M.V.I. ADULT (PHARMACY BULK PACKAGE)

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 200MG/5ML;0.06MG/5ML;0.005MG/5ML;15MG/5ML;0.005MG/5ML;0.6MG/5ML;40MG/5ML;6MG/5ML;3.6MG/5ML;6MG/5ML;1MG/5ML;10MG/5ML;0.15MG/5ML

Approval Date : 2004-02-18

Application Number : 21643

RX/OTC/DISCN : DISCN

RLD : Yes

TE Code :

blank

08

SANDOZ CANADA INC

Switzerland
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

SANDOZ CANADA INC

Switzerland
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K

Brand Name : INFUVITE ADULT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

Approval Date : 2000-05-18

Application Number : 21163

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

09

SANDOZ CANADA INC

Switzerland
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

SANDOZ CANADA INC

Switzerland
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K

Brand Name : INFUVITE ADULT

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

Approval Date : 2003-06-16

Application Number : 21163

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

10

SANDOZ CANADA INC

Switzerland
Vietnam Medi-Pharm Expo
Not Confirmed
arrow

SANDOZ CANADA INC

Switzerland
arrow
Vietnam Medi-Pharm Expo
Not Confirmed

ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K

Brand Name : INFUVITE PEDIATRIC

Dosage Form : INJECTABLE;INTRAVENOUS

Dosage Strength : 80MG/VIAL;0.02MG/VIAL;400 IU/VIAL;0.001MG/VIAL;5MG/VIAL;0.14MG/VIAL;17MG/VIAL;1MG/VIAL;1.4MG/VIAL;1.2MG/VIAL;7 IU/VIAL;2,300 IU/VIAL;0.2MG/VIAL

Approval Date : 2001-02-21

Application Number : 21265

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - FOR SOLUTION;INTRAVENOUS - 80MG/VIAL...DOSAGE - FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL

USFDA APPLICATION NUMBER - 18920

read-more

DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/...DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML

USFDA APPLICATION NUMBER - 21163

read-more

DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/...DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML

USFDA APPLICATION NUMBER - 21163

read-more

DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;...DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL

USFDA APPLICATION NUMBER - 21625

read-more

DOSAGE - INJECTABLE;INJECTION - 20MG/ML;0.006...DOSAGE - INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML

USFDA APPLICATION NUMBER - 8809

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Topical

read-more
read-more

Solubilizers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Taste Masking

read-more
read-more

Emulsifying Agents

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Direct Compression

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Coating Systems & Additives

read-more
read-more

API Stability Enhancers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Granulation

read-more
read-more

Co-Processed Excipients

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Rheology Modifiers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Soft Gelatin

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

Analytical Methods

read-more
read-more

01

arrow
Arvo
Not Confirmed

YMC

Japan
arrow
Arvo
Not Confirmed

YMC-Pack Polyamine II

Product Code : PB12S05-2546WT

Classification : Vitamins

Product Characteristics : J030624B

Category :

Description :

blank

ABOUT THIS PAGE

Looking for 81-13-0 / D-Panthenol API manufacturers, exporters & distributors?

D-Panthenol manufacturers, exporters & distributors 1

100

PharmaCompass offers a list of D-Panthenol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right D-Panthenol manufacturer or D-Panthenol supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred D-Panthenol manufacturer or D-Panthenol supplier.

API | Excipient name

D-Panthenol

Synonyms

81-13-0, Pantothenol, Ilopan, D-pantothenyl alcohol, Bepanthen, Pantol

Cas Number

81-13-0

Unique Ingredient Identifier (UNII)

1O6C93RI7Z

About D-Panthenol

Dexpanthenol is a metabolite found in the aging mouse brain.

Motilyn Manufacturers

A Motilyn manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Motilyn, including repackagers and relabelers. The FDA regulates Motilyn manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Motilyn API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Motilyn manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Motilyn Suppliers

A Motilyn supplier is an individual or a company that provides Motilyn active pharmaceutical ingredient (API) or Motilyn finished formulations upon request. The Motilyn suppliers may include Motilyn API manufacturers, exporters, distributors and traders.

click here to find a list of Motilyn suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Motilyn USDMF

A Motilyn DMF (Drug Master File) is a document detailing the whole manufacturing process of Motilyn active pharmaceutical ingredient (API) in detail. Different forms of Motilyn DMFs exist exist since differing nations have different regulations, such as Motilyn USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Motilyn DMF submitted to regulatory agencies in the US is known as a USDMF. Motilyn USDMF includes data on Motilyn's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Motilyn USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Motilyn suppliers with USDMF on PharmaCompass.

Motilyn JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Motilyn Drug Master File in Japan (Motilyn JDMF) empowers Motilyn API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Motilyn JDMF during the approval evaluation for pharmaceutical products. At the time of Motilyn JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Motilyn suppliers with JDMF on PharmaCompass.

Motilyn CEP

A Motilyn CEP of the European Pharmacopoeia monograph is often referred to as a Motilyn Certificate of Suitability (COS). The purpose of a Motilyn CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Motilyn EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Motilyn to their clients by showing that a Motilyn CEP has been issued for it. The manufacturer submits a Motilyn CEP (COS) as part of the market authorization procedure, and it takes on the role of a Motilyn CEP holder for the record. Additionally, the data presented in the Motilyn CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Motilyn DMF.

A Motilyn CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Motilyn CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Motilyn suppliers with CEP (COS) on PharmaCompass.

Motilyn NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Motilyn as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Motilyn API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Motilyn as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Motilyn and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Motilyn NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Motilyn suppliers with NDC on PharmaCompass.

Motilyn GMP

Motilyn Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Motilyn GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Motilyn GMP manufacturer or Motilyn GMP API supplier for your needs.

Motilyn CoA

A Motilyn CoA (Certificate of Analysis) is a formal document that attests to Motilyn's compliance with Motilyn specifications and serves as a tool for batch-level quality control.

Motilyn CoA mostly includes findings from lab analyses of a specific batch. For each Motilyn CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Motilyn may be tested according to a variety of international standards, such as European Pharmacopoeia (Motilyn EP), Motilyn JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Motilyn USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty